Peptic Ulcers
Peptic Ulcers - Related Videos
01:27
Peptic Ulcer
0 Views •
2026
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:28
Peptic Ulcer Disease II: Pathophysiology
0 Views •
2025
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements. Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells. Helicobacter pylori Infection: Peptic ulcers result from H. pylori infections.
01:24
Peptic Ulcer Disease II: Pathophysiology
0 Views •
2026
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:25
Peptic Ulcer Disease I: Introduction
0 Views •
2026
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
01:30
Peptic Ulcer Disease I: Introduction
0 Views •
2025
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement. An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue. Peptic ulcers can also be...
FAQs
The key imbalance is between aggressive luminal factors and epithelial defenses. Gastric acid and pepsin can injure tissue when mucus and bicarbonate no longer provide adequate protection at the mucosal surface. This relationship makes peptic ulcers useful for examining gastrointestinal physiology: disease develops not from acid alone, but from failure of coordinated protective mechanisms.
H. pylori infection links peptic ulcers to a host–microbe interaction in which a microorganism contributes to weakening stomach or duodenal mucosal defenses. The resulting injury is also relevant to inflammation, because ulcer biology includes both microbial influence and the host tissue response. This framework connects infection with barrier failure and tissue damage.
Long-term NSAID use represents a separate contributing pathway from H. pylori infection. These medications can weaken mucus and bicarbonate defenses, leaving underlying tissue more exposed to gastric acid and pepsin. Comparing the two pathways shows that similar mucosal injury can arise from different initiating factors, which matters when selecting treatment.
Treatment can pursue more than symptom control. The main strategies are eradicating H. pylori when infection is involved, reducing acid secretion, and removing contributing medications. These approaches target different parts of the disease process. Effective management also aims to prevent recurrence and serious outcomes, including bleeding and perforation.
Management is important because ulcer disease can lead to bleeding and perforation, in addition to recurrence. Treatment therefore functions as prevention as well as repair: eradicating H. pylori, reducing acid secretion, or removing contributing medications addresses causes that could otherwise continue to damage the mucosa. These possible outcomes explain the clinical importance of controlling the underlying process.
Peptic ulcers bring together several biological themes in one disease process: host–microbe interactions, inflammation, tissue repair, and gastrointestinal physiology. Researchers can examine how an infectious factor or medication-related weakening of defenses is followed by tissue injury and repair. The topic therefore connects biological mechanisms with clinically important outcomes such as recurrence, bleeding, and perforation.